Pseudopeptide bradykinin receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530329, 530314, A61K 3808

Patent

active

055211585

ABSTRACT:
The invention relates to peptides of up to 10 amino acids that are synthesized by substituting at least one of the bradykinin amino acids found in positions 2, 3, 4 and 5 of the bradykinin peptide with a fatty acid amine. The modified bradykinin peptides produced confer increased resistance to enzymatic degradation and/or tissue specificity. The invention also relates to pharmaceutical preparations and processes of treatments using the modified bradykinin peptides.

REFERENCES:
patent: 4242329 (1980-12-01), Claeson et al.
patent: 4693993 (1987-09-01), Stewart et al.
patent: 4801613 (1989-01-01), Stewart et al.
patent: 5385889 (1995-01-01), Kyle
Journal of Medicine Chemistry, 1991, vol. 34, No. 8, pp. 2649-2653.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pseudopeptide bradykinin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pseudopeptide bradykinin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pseudopeptide bradykinin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-786746

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.